Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Goldhirsch

Showing results (171-180 of 753) with videos related to

Pageof 76
Sort By:
Discovery Medicine|August 14, 2010
Breast cancerUmberto Veronesi, Aron Goldhirsch, Peter Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?Arnie Purushotham, Sarah Pinder, Massi Cariati, et al.
Deutsche Medizinische Wochenschrift (1946)|October 14, 1977
[Prolymphocytic leukaemia: a new clinical entity (author's transl)]F Cavalli, E Pedrinis, J Ludin, et al.
Experientia. Supplementum|January 1, 1982
Post-operative adjuvant trials in breast cancer--the Swiss group and the Ludwig International groupW F Jungi, H J Senn, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2011
Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancerS Zurrida, E Montagna, P Naninato, et al.
Clinical Breast Cancer|August 14, 2010
Axillary lymph node involvement in women with breast cancer: does it depend on age?Edoardo Botteri, Vincenzo Bagnardi, Aaron Goldhirsch, et al.
Breast (Edinburgh, Scotland)|July 4, 2006
Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005)Saverio Cinieri, Marco Colleoni, Stefano Zurrida, et al.
Schweizerische Medizinische Wochenschrift|June 25, 1977
[Bone destructive foci as precursors of the blastic crisis in chronic myelocytic leukemia]F Cavalli, E Pedrinis, G Mombelli, et al.
Seminars in Oncology|June 1, 1995
Dose-finding study of paclitaxel and cyclophosphamide in patients with advanced breast cancerC Sessa, O Pagani, G Parma, et al.
Lancet (London, England)|September 22, 1990
Occult axillary lymph-node micrometastases in breast cancerA M Neville, R Bettelheim, R D Gelber, et al.
Pageof 76

Showing results (171-180 of 753) with videos related to

Sort By:
Pageof 76
Discovery Medicine|August 14, 2010
Breast cancerUmberto Veronesi, Aron Goldhirsch, Peter Boyle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 8, 2010
Neoadjuvant chemotherapy: not the best option in estrogen receptor-positive, HER2-negative, invasive classical lobular carcinoma of the breast?Arnie Purushotham, Sarah Pinder, Massi Cariati, et al.
Deutsche Medizinische Wochenschrift (1946)|October 14, 1977
[Prolymphocytic leukaemia: a new clinical entity (author's transl)]F Cavalli, E Pedrinis, J Ludin, et al.
Experientia. Supplementum|January 1, 1982
Post-operative adjuvant trials in breast cancer--the Swiss group and the Ludwig International groupW F Jungi, H J Senn, A Goldhirsch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 2011
Receptor status (ER, PgR and HER2) discordance between primary tumor and locoregional recurrence in breast cancerS Zurrida, E Montagna, P Naninato, et al.
Clinical Breast Cancer|August 14, 2010
Axillary lymph node involvement in women with breast cancer: does it depend on age?Edoardo Botteri, Vincenzo Bagnardi, Aaron Goldhirsch, et al.
Breast (Edinburgh, Scotland)|July 4, 2006
Innovation in care and research: meeting highlights from the seventh Milan Breast Cancer Conference (Milan, 15-17 June, 2005)Saverio Cinieri, Marco Colleoni, Stefano Zurrida, et al.
Schweizerische Medizinische Wochenschrift|June 25, 1977
[Bone destructive foci as precursors of the blastic crisis in chronic myelocytic leukemia]F Cavalli, E Pedrinis, G Mombelli, et al.
Seminars in Oncology|June 1, 1995
Dose-finding study of paclitaxel and cyclophosphamide in patients with advanced breast cancerC Sessa, O Pagani, G Parma, et al.
Lancet (London, England)|September 22, 1990
Occult axillary lymph-node micrometastases in breast cancerA M Neville, R Bettelheim, R D Gelber, et al.
Pageof 76